Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Megestrol Acetate Plus LNG-IUS to Megestrol Acetate in Young Women With Early Endometrial Cancer
Sponsor: Fudan University
This PHASE2/PHASE3 trial investigates Endometrial Neoplasm Malignant Stage I and is currently completed. Fudan University leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Jun 2020 — Dec 2020 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 5 earlier versions
-
Nov 2019 — Jun 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2018 — Nov 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Active Not Recruiting → Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .